Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging A Agarwal, SW Huang, M O’donnell, KC Day, M Day, N Kotov, ... Journal of applied physics 102 (6), 2007 | 554 | 2007 |
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 346 | 1998 |
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab S Ithimakin, KC Day, F Malik, Q Zen, SJ Dawsey, TF Bersano-Begey, ... Cancer research 73 (5), 1635-1646, 2013 | 276 | 2013 |
Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging G Kim, SW Huang, KC Day, M O’Donnell, RR Agayan, MA Day, ... Journal of biomedical optics 12 (4), 044020-044020-8, 2007 | 246 | 2007 |
The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation AJ Najy, KC Day, ML Day Journal of Biological Chemistry 283 (26), 18393-18401, 2008 | 225 | 2008 |
The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells J Rios-Doria, KC Day, R Kuefer, MG Rashid, AM Chinnaiyan, MA Rubin, ... Journal of Biological Chemistry 278 (2), 1372-1379, 2003 | 207 | 2003 |
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. EJ Haskel, SR Torr, KC Day, MO Palmier, TC Wun, BE Sobel, ... Circulation 84 (2), 821-827, 1991 | 181 | 1991 |
E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway ML Day, X Zhao, CJ Vallorosi, M Putzi, CT Powell, C Lin, KC Day Journal of Biological Chemistry 274 (14), 9656-9664, 1999 | 162 | 1999 |
HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone KC Day, GL Hiles, M Kozminsky, SJ Dawsey, A Paul, LJ Broses, R Shah, ... Cancer research 77 (1), 74-85, 2017 | 160 | 2017 |
Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway ML Day, RG Foster, KC Day, X Zhao, P Humphrey, P Swanson, ... Journal of Biological Chemistry 272 (13), 8125-8128, 1997 | 146 | 1997 |
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease R Kuefer, KC Day, CG Kleer, MS Sabel, MD Hofert, S Varambally, ... Neoplasia 8 (4), 319-329, 2006 | 138 | 2006 |
Truncation of the β-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution CJ Vallorosi, KC Day, X Zhao, MG Rashid, MA Rubin, KR Johnson, ... Journal of Biological Chemistry 275 (5), 3328-3334, 2000 | 128 | 2000 |
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma M Hussain, S Daignault, N Agarwal, PD Grivas, AO Siefker‐Radtke, ... Cancer 120 (17), 2684-2693, 2014 | 123 | 2014 |
Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit KC Day, LC Hoffman, MO Palmier, KK Kretzmer, MD Huang, EY Pyla, ... | 121 | 1990 |
ADAM15 supports prostate cancer metastasis by modulating tumor cell–endothelial cell interaction AJ Najy, KC Day, ML Day Cancer research 68 (4), 1092-1099, 2008 | 114 | 2008 |
Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following … Y Asada, S Hara, A Tsuneyoshi, K Hatakeyama, A Kisanuki, K Marutsuka, ... Thrombosis and haemostasis 80 (09), 506-511, 1998 | 95 | 1998 |
Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance R Panvichian, K Orth, ML Day, KC Day, MJ Pilat, KJ Pienta Cancer research 58 (20), 4667-4672, 1998 | 94 | 1998 |
Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells X Zhao, JE Gschwend, CT Powell, RG Foster, KC Day, ML Day Journal of Biological Chemistry 272 (36), 22751-22757, 1997 | 81 | 1997 |
Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity A Li, TC Wun Thrombosis and haemostasis 80 (09), 423-427, 1998 | 71 | 1998 |
Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications DH Hovelson, AM Udager, AS McDaniel, P Grivas, P Palmbos, S Tamura, ... European Urology 74 (6), 741-753, 2018 | 61 | 2018 |